Outset Medical (OM) Price & Analysis

Compare

383 Followers

OM Stock Chart & Stats

$15.53

-$0.10(-9.09%)

At close: Jan 08 4:00 PM EST

$15.53

-$0.10(-9.09%)

Day’s Range― - ―

52-Week Range$4.13 - $25.35

Previous CloseN/A

Volume1.92M

Average Volume (3M)604.92K

Market Cap

$76.52M

Enterprise Value$174.98M

Total Cash (Recent Filing)$178.64M

Total Debt (Recent Filing)$3.16M

Price to Earnings (P/E)―

Beta1.58

Next Earnings

Feb 17, 2026

EPS Estimate

-0.68

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.69

Shares Outstanding18,153,090

10 Day Avg. Volume566,165

30 Day Avg. Volume604,922

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)2.15

Price to Sales (P/S)0.51

P/FCF Ratio-0.49

Enterprise Value/Market Cap2.29

Enterprise Value/Revenue1.46

Enterprise Value/Gross Profit3.87

Enterprise Value/Ebitda-2.51

Forecast

1Y Price Target

$15.75

Price Target Upside1.42% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering4

EPS Forecast (FY)-4.31

Revenue Forecast (FY)$124.08M

Bulls Say, Bears Say

Bulls Say

Cost ManagementOperating expenses were down nearly 20% year over year, and the company used less than $6M of cash during Q3, indicating efficient cost management.

Product SalesQ3 saw an 8% increase in Tablo console sales, contributing to a 3% improvement in overall revenue.

Technological InnovationThe Tablo hemodialysis system is seen as having game-changing technology potential with ongoing opportunities for broad US adoption.

Bears Say

Revenue Guidance CutOM cut its full-year revenue outlook to $115M-$120M from a prior $122M-$126M.

Revenue ShortfallOutset Medical reported Q3 revenue of $29.4M, falling short of the consensus estimate of $30.7M.

Salesforce DisruptionThe recent departure of OM's head of sales potentially resulting in some salesforce disruption during a crucial time.

Outset Medical News

Outset Medical management to meet virtually with BTIG

Virtual Meeting to be held on December 11 hosted by BTIG. Published first on TheFly – the ultimate...

10h ago

Outset Medical price target lowered to $17 from $22 at RBC Capital

RBC Capital analyst Shagun Singh lowered the firm’s price target on Outset Medical (OM) to $17 from $22...

23d ago

Outset Medical price target lowered to $15 from $25 at TD Cowen

TD Cowen analyst Joshua Jennings lowered the firm’s price target on Outset Medical (OM) to $15 from $25...

23d ago

Outset Medical price target lowered to $14 from $17 at Stifel

Stifel lowered the firm’s price target on Outset Medical (OM) to $14 from $17 and keeps a Buy...

23d ago

Outset Medical price target lowered to $17 from $39 at BTIG

BTIG analyst Marie Thibault lowered the firm’s price target on Outset Medical (OM) to $17 from $39 and...

23d ago

Outset Medical reports Q3 EPS ($1.00), consensus (65c)

Reports Q3 revenue $29.4M, consensus $30.7M. Total cash, including restricted cash, cash equivalents and short-term investments, was $182M...

23d ago

Outset Medical lowers FY25 revenue outlook to $115M-$120M from $122M-$126M

Consensus $124.03M. FY25 non-GAAP gross margin guidance remains unchanged, still expected to be in the high-30% range. Additionally,...

23d ago

Outset Medical’s Earnings Call: Mixed Signals and Future Prospects

Outset Medical, Inc. (($OM)) has held its Q3 earnings call. Read on for the main highlights of the...

22d ago

Outset Medical’s Growth Potential: Buy Rating Despite Q3 Challenges

Josh Jennings, an analyst from TD Cowen, maintained the Buy rating on Outset Medical. The associated price target...

23d ago

Outset Medical’s Q3 2025 Earnings and Outlook

Outset Medical, Inc. ( ($OM) ) has released its Q3 earnings. Here is a breakdown of the information...

23d ago

OM Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Outset Medical, Inc. (OM) is scheduled to report 3rd quarter earnings on 11/10/2025, after the market closes. Regarding...

26d ago

Outset Medical announces collaboration Northwest Kidney Centers

Northwest Kidney Centers announced a collaboration with Outset Medical (OM). Through the collaboration, Northwest Kidney Centers will add...

3M ago

Outset Medical’s Earnings Call Highlights Strong Growth

Outset Medical, Inc. (($OM)) has held its Q2 earnings call. Read on for the main highlights of the...

4M ago

Outset Medical Reports Strong Q2 Growth and Raises Guidance

Outset Medical, Inc. ( ($OM) ) has released its Q2 earnings. Here is a breakdown of the information...

4M ago

OM FAQ

What was Outset Medical, Inc.’s price range in the past 12 months?

Outset Medical, Inc. lowest stock price was $4.13 and its highest was $25.35 in the past 12 months.

What is Outset Medical, Inc.’s market cap?

Outset Medical, Inc.’s market cap is $76.52M.

When is Outset Medical, Inc.’s upcoming earnings report date?

Outset Medical, Inc.’s upcoming earnings report date is Feb 17, 2026 which is in 75 days.

How were Outset Medical, Inc.’s earnings last quarter?

Outset Medical, Inc. released its earnings results on Nov 10, 2025. The company reported -$0.69 earnings per share for the quarter, missing the consensus estimate of -$0.655 by -$0.035.

Is Outset Medical, Inc. overvalued?

According to Wall Street analysts Outset Medical, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Outset Medical, Inc. pay dividends?

Outset Medical, Inc. does not currently pay dividends.

What is Outset Medical, Inc.’s EPS estimate?

Outset Medical, Inc.’s EPS estimate is -0.68.

How many shares outstanding does Outset Medical, Inc. have?

Outset Medical, Inc. has 18,153,090 shares outstanding.

What happened to Outset Medical, Inc.’s price movement after its last earnings report?

Outset Medical, Inc. reported an EPS of -$0.69 in its last earnings report, missing expectations of -$0.655. Following the earnings report the stock price went down -48.467%.

Which hedge fund is a major shareholder of Outset Medical, Inc.?

Currently, no hedge funds are holding shares in OM

Outset Medical Stock Smart Score

Underperform

Fundamentals

Return on Equity

-92.33%

Trailing 12-Months

Asset Growth

-5.34%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Outset Medical, Inc.

Outset Medical (OM) is a medical technology company focused on transforming the way dialysis is delivered to patients. The company operates within the healthcare sector, specifically targeting renal care, with a core product offering of the Tablo Hemodialysis System. This innovative system simplifies the dialysis process for both patients and healthcare providers, enabling efficient treatment in various settings, including in-home and clinic environments.

Outset Medical (OM) Earnings & Revenues

Historic Earnings Reports

OM Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call presented a mixed outlook for Outset Medical. While there were positives such as increased console sales, improved gross margins, and a strong cash position, the company faced challenges with revenue growth, leadership changes, and deal closing timing. The uncertainty about future sales leadership and the revision of revenue guidance contributed to a cautious outlook.View all OM earnings summaries

OM Revenue Breakdown

47.04% Consoles

32.37% Consumables

20.59% Service and other revenue

OM Stock 12 Month Forecast

Average Price Target

$15.75

▲(1.42% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","21":"$21","11.25":"$11.25","14.5":"$14.5","17.75":"$17.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$17.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,11.25,14.5,17.75,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.12,13.418461538461537,13.716923076923075,14.015384615384615,14.313846153846153,14.612307692307692,14.91076923076923,15.209230769230768,15.507692307692308,15.806153846153846,16.104615384615386,16.403076923076924,16.701538461538462,{"y":17,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.12,13.322307692307692,13.524615384615384,13.726923076923077,13.929230769230768,14.131538461538462,14.333846153846153,14.536153846153846,14.738461538461538,14.94076923076923,15.143076923076922,15.345384615384615,15.547692307692309,{"y":15.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.12,13.187692307692307,13.255384615384616,13.323076923076922,13.39076923076923,13.458461538461538,13.526153846153846,13.593846153846153,13.661538461538461,13.72923076923077,13.796923076923077,13.864615384615384,13.932307692307692,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9.15,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.58,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.65,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.92,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.91,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.17,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.81,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.73,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.04,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.12,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >